Abstract:Introduction: An F-18-labeled positron emission tomography (PET) tracer for amyloid plaque is desirable for early diagnosis of Alzheimer's disease, particularly to enable preventative treatment once effective therapeutics are available. Similarly, such a tracer would be useful as a biomarker for enrollment of patients in clinical trials for evaluation of antiamyloid therapeutics. Furthermore; changes in the level of plaque burden as quantified by an amyloid plaque PET tracer may provide valuable insights into the effectiveness of amyloid-targeted therapeutics. This work describes our approach to evaluate and select a candidate PET tracer for in vivo quantification of human amyloid plaque.Methods: Ligands were evaluated for their in vitro-binding to human amyloid plaques, lipophilicity and predicted blood brain barrier permeability. Candidates with favorable in vitro properties were radiolabeled with F-18 and evaluated in vivo. Baseline PET scans in rhesus monkey were conducted to evaluate the regional distribution and kinetics of each tracer using tracer kinetic modeling methods. High binding potential in cerebral white matter and cortical grey matter was considered an unfavorable feature of the candidate tracers.Results: [F-18]MK-3328 showed the most favorable combination of low in vivo binding potential in white matter and cortical grey matter in rhesus monkeys, low lipophilicity (Log D=2.91) and high affinity for human amyloid plaques (IC50=10.5 +/- 1.3 nM).Conclusions: [F-18]MK-3328 was identified as a promising PET tracer for in vivo quantification of amyloid plaques, and further evaluation in humans is warranted. (C) 2011 Elsevier Inc. All rights reserved.

Synthesis and Monkey-PET Study of (R)- and (S)-18F-labeled 2-Arylbenzoheterocyclic Derivatives As Amyloid Probes with Distinctive in Vivo Kinetics.

(R)- and (S)-18F-labeled 2-Arylbenzofurans with Improved Pharmacokinetics As Β-Amyloid Imaging Probes.

Synthesis and Evaluation of Novel ¹⁸F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives As Ligands for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques.

Preliminary Characterization and In Vivo Studies of Structurally Identical 18 F- and 125 I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques

Synthesis and Biological Evaluation of 18F-Labled 2-Phenylindole Derivatives As PET Imaging Probes for Β-Amyloid Plaques

Preliminary Characterization and in Vivo Studies of Structurally Identical 18F- and 125I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of Β-Amyloid Plaques

18F-Labeled 2-Phenylbenzoheterocycles with Chiral Dihydroxyl Side Chains As Β-Amyloid Imaging Probes.

18F-Labeled Benzyldiamine Derivatives As Novel Flexible Probes for Positron Emission Tomography of Cerebral Β-Amyloid Plaques.

Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques in Alzheimer’s Brains

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

18F-Labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques

18F-Radiolabeled Resveratrol Derivatives: Synthesis, Radiolabeling, and Preliminary Evaluation as β-Amyloid Plaque PET Agents

[18F]fluoroazabenzoxazoles As Potential Amyloid Plaque PET Tracers: Synthesis and in Vivo Evaluation in Rhesus Monkey.

Design, Synthesis, and Preliminary Evaluation of [18F]-Aryl Flurosulfates PET Radiotracers Via SuFEx Methods for Β-Amyloid Plaques in Alzheimer’s Disease

Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β -amyloid plaques by positron emission tomography

99Mtc-Labeled 2-Arylbenzothiazoles: Aβ Imaging Probes with Favorable Brain Pharmacokinetics for Single-Photon Emission Computed Tomography.

(99M)tc-Labeled-2-arylbenzoxazole Derivatives As Potential Aβ Imaging Probes for Single-Photon Emission Computed Tomography.

Fluorine-18-Labeled Diaryl-azines As Improved Β-Amyloid Imaging Tracers: from Bench to First-in-Human Studies

Radiolabeled pyridinyl analogues of dibenzylideneacetone as beta-amyloid imaging probes

Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.